These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 26812693)

  • 21. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
    Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
    Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia.
    Abd-El-Fattah AA; Sadik NA; Shaker OG; Aboulftouh ML
    Cell Biochem Biophys; 2013; 67(3):875-84. PubMed ID: 23559272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
    El-Hamouly MS; Azzam AA; Ghanem SE; El-Bassal FI; Shebl N; Shehata AMF
    Mol Biol Rep; 2019 Dec; 46(6):5759-5765. PubMed ID: 31471732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
    El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.
    Zhang ZQ; Meng H; Wang N; Liang LN; Liu LN; Lu SM; Luan Y
    Diagn Pathol; 2014 Jul; 9():135. PubMed ID: 24993656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
    Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
    Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
    BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients.
    Abdel-Al A; El-Ahwany E; Zoheiry M; Hassan M; Ouf A; Abu-Taleb H; Abdel Rahim A; El-Talkawy MD; Zada S
    Virus Res; 2018 Jul; 253():135-139. PubMed ID: 29932949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
    Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
    Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
    An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
    World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
    Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
    Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
    Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC.
    Yosry A; Zayed N; Dawood RM; Ibrahim MK; Elsharkawy M; Ekladious SM; Khairy A; Elsharkawy A; Khairy M; Abdel Alem S; Bader El Din NG; El Awady MK; Abdellatif Z
    Lab Med; 2022 Sep; 53(5):523-529. PubMed ID: 35731638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.